Comprehensive Assessment of Histopathologic and Physiologic Profile in Esophageal Motility Disorders

Who is this study for? Patients with esophageal motility disorders
What treatments are being studied? Atropine challenge+Esophageal muscle biopsy
Status: Recruiting
Location: See all (2) locations...
Intervention Type: Procedure, Drug
Study Type: Interventional
Study Phase: Phase 4
SUMMARY

The prospective clinical trial will study muscle fibrosis in relation to lower esophageal sphincter (LES) measurements on Functional Lumen Imaging Probe (FLIP) Topography (the novel technology that utilizes impedance planimetry) after pharmacologic challenge. A better understanding of achalasia will allow intervention at an earlier stage.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Male or female patients, age 18 and above.

• Evaluated by Emory Digestive Diseases Clinic, Emory Motility Lab, the Emory Endoscopy Unit, or Emory Surgery Department from October 1, 2020, to September 30, 2024.

• Has a diagnosis of achalasia or an esophageal motility disorder with confirmed evaluation by one of the following modalities: functional lumen imaging probe (FLIP) or high-resolution esophageal manometry (for Aim 1)

• Undergoing a diagnostic Functional Lumen Imaging Probe (FLIP) study at Emory University Hospital with anesthesia assistance (for Aim 1)

• Undergoing Heller myotomy or per oral endoscopic myotomy for the treatment of their esophageal motility disorder (for Aim 2)

Locations
United States
Georgia
Emory Saint Joseph's Hospital
RECRUITING
Atlanta
Emory University Hospital
RECRUITING
Atlanta
Contact Information
Primary
Anand Jain, MD
anand.jain@emory.edu
404-778-3184
Time Frame
Start Date: 2021-03-17
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 80
Treatments
Experimental: Pharmacologic challenge
Measurement of esophageal response to atropine using functional lumen imaging probe (FLIP)
Related Therapeutic Areas
Sponsors
Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Leads: Emory University

This content was sourced from clinicaltrials.gov